| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 440.1K | $18.75M | -64,000 | |
| Other | 138.6K | $5.90M | -7,215 | |
| Other | 123.1K | $5.24M | - | |
| CFO | 116.9K | $4.98M | -8,327 | |
| Other | 111.5K | $4.75M | -8,233 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Inrig Jula45 | Chief Medical Officer | Sell | 8,233 | $42.01 | $345,893.27 | -3.5% | - | - | |
| Apr 15, 2026 | Reed Elizabeth E58 | Chief Legal Officer And GC | Sale+OE | 51,500 | $41.29 | $2,126,451.68 | -10.4% | - | - | |
| Apr 15, 2026 | Cline Christopher R.50 | Chief Financial Officer | Sell | 8,327 | $41.91 | $348,974.00 | -1.7% | - | - | |
| Apr 15, 2026 | Dube Eric M57 | Chief Executive Officer | Sell | 64,000 | $41.09 | $2,629,975.10 | -4.7% | - | - | |
| Apr 14, 2026 | Heerma Peter53 | Chief Commercial Officer | Sell | 7,215 | $41.93 | $302,516.29 | -4.9% | - | - | |
| Feb 3, 2026 | Inrig Jula45 | Chief Medical Officer | Sell | 6,956 | $32.12 | $223,426.72 | -6.1% | +34.3% | - | |
| Feb 3, 2026 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sell | 4,333 | $32.12 | $139,175.96 | -8.1% | +34.3% | - | |
| Feb 3, 2026 | Reed Elizabeth E58 | Chief Legal Officer And GC | Sell | 7,175 | $32.12 | $230,461.00 | -6.2% | +34.3% | - | |
| Feb 3, 2026 | Dube Eric M57 | Chief Executive Officer | Sell | 100,087 | $32.28 | $3,230,315.62 | -10.0% | +34.3% | - | |
| Feb 3, 2026 | Cline Christopher R.50 | Chief Financial Officer | Sell | 7,242 | $32.12 | $232,613.04 | -6.0% | +34.3% | - |